Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Acadia Pharmaceuticals, Inc. (NQ: ACAD)
20.55 USD  +0.41 (+2.04%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 24, 2014  /  Add to My Watchlist      
(ACAD) Community Analysis from
April 24, 2014
(Samurai Trader, 4/11/13)
ACAD has been on the relative strength list for months, but thanks to the scale of the chart, looks like it hasn't done much since last November. That is very misleading: this actually had a range where the op was more...(read more)
See why these stocks are moving the markets after-hours and will be widely watched at tomorrow's opening bell ...
(Stock Blog Hub, 10/28/10)
This morning, Acadia Pharmaceuticals (ACAD) announced that it has entered into an agreement with Biovail Labs (BLS), a wholly owned subsidiary of Valeant Pharmaceuticals...(read more)
ACADIA Pharmaceuticals (ACAD) Company Overview

There is no analysis for ACAD yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here